Application of an antibody biochip for p53 detection and cancer diagnosis

Biotechnology Progress

Volumn 17, Issue 3, 2001, Pages 543-552

  Askari, M ^a   Alarie, J P ^a   Moreno Bondi, M ^a   Vo Dinh, T ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MATRICES;

ANTIGEN ANTIBODY REACTION; BIOCHIP; BIOTECHNOLOGICAL PROCEDURES; CANCER CELL; COMPLEX FORMATION; CYANINE DYE; DISEASE DETECTION; DISEASE DIAGNOSIS; EQUIPMENT DESIGN; EQUIPMENT; HUMAN CELL; PROTEIN P53; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANTIBODIES; ANTIGENS; DIAGNOSIS; DYES; GENES; TISSUE; TUMORS;

BIOTECHNOLOGY;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; BIOSENSING TECHNIQUES; HUMANS; IMMUNOASSAY; LASERS; NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034975111     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp010008s     Document Type: Article

References (56)

1. Common cancers-genetics, origin, prevention, screening: Parts I and II
2. Molecular genetics of gynecologic cancer
3. Detection of heterozygous mutations in BRCA1 using high-density oligonucleotide arrays and two-colour fluorescence analysis
4. American Joint Committee on Cancer prognostic factors consensus conference
5. Role of tumor marker in the presymptomatic diagnosis of hereditary malignant tumors
6. Potential biomarkers for the early detection of lung cancer
7. Prostate-specific antigen
8. Serum p53 antibody assay: Evaluation in colorectal cancer
9. Overview on human breast cancer with focus on prognostic and predictive factors with special attention on the tumour suppressor gene p53
10. Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: Subanalysis in node-positive and node-negative patients
11. Prognostic value of p53 gene mutations in a large series of node-negative breast cancer patients
12. Early detection and prevention of lung cancer
13. Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis
14. Suppression of p53: A new approach to overcome side effects of antitumor therapy
15. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum
16. P53 antibodies: A new method for the analysis of alterations of the p53 gene: Application to breast cancer
17. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999
18. p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma
19. p53 overexpression in advanced-stage endometrial adenocarcinoma
20. p53 protein detection by the western blotting technique in normal and neoplastic specimens of human endometrium
21. Clinical significance of serum p53 antigen in patients with pancreatic carcinomas
22. Clinical significance of serum p53 antibody in patients with gastric cancer
23. Immunohistochemical detection of p53 protein in neoplastic, preneoplastic and normal bronchial mucosa specimens obtained during diagnostic bronchoscopy
24. Apoptosis regulating genes in prostate cancer
25. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma
26. Increased serum levels of mutant p53 proteins in patients with colorectal cancer
27. The role of the soluble p53 antigen and its autoantibodies as markers for diagnosis of colon cancer, a comparative study
28. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma
29. Serological and immunohistochemical determinations of p53 protein in diagnosis of endometrial cancer: A comparative study
30. Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detection
31. A study on p53 protein and anti-p53 antibodies in the sera of patients with oesophageal cancer
32. Sensitivity enhancement of optical immunosensors with nanoparticles
33. Single-target molecule detection with nonbleaching multicolor optical immunolabels
34. Preliminary study of real-time fiber optic based protein C biosensor
35. Fiber optic-based biosensor for ricin
36. Sol-gel-based biosensors for use in stroke treatment
37. Detection of multiple toxic agents using a planar array immunosensor
38. Development of a DNA biochip for gene diagnosis
39. DNA biochip using phototransitor integrated circuit
40. Development of a DNA biochip: Principle and applications
41. Antibody-antigen binding kinetics. A model for multivalency antibodies for large antigen systems
42. Evaluation of the fiber-optic antibody-based fluoroimmunosensor for DNA adducts in human placenta samples
43. Development of antibody-based fiber-optic sensors for detection of a benzo[a]pyrene metabolite
44. Fiber-optic chemical sensors for competitive binding fluoroimmunoassay
45. Rapid determination of single base mismatch mutations in DNA hybrids by direct electric field control
46. Simultaneous assay of ErbB-2 protein and carcinoembryonic antigen in cyst fluid as an aid in diagnosing cystic lesions of the breast
47. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis
48. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and nonmammary tissue
49. Solid pseudopapillary tumor of the pancreas: Immunohistochemical localization of neuroendocrine markers and CD10
50. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas
51. Circulating antibodies against p53 protein in patients with ovariancarcinoma. Correlation with clinicopathologic features and survival
52. Cytosolic p53 protein and serum p53 autoantibody evaluation in breast cancer. Comparison with prognostic factors
53. The role of the soluble p53 antigen and its autoantibodies as markers for diagnosis of colon cancer: A comparative study
54. Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma
55. p53 autoantibodies in patients with pancreatitis and pancreatic carcinoma
56. The role of blood levels of soluble 53 kDa protein and CEA in monitoring colon cancer patients